This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
Since the first of the year, the price of Hologic, Inc. (HOLX) has swelled 55%. Hologic develops, manufactures, and markets x-ray systems. The volume of trades has grown significantly in the past week, up 163.2%. For more information, get Portfolio Grader’s complete analysis of HOLX stock.
Shares of Allergan plc (AGN) have risen 55.8% since January 1. Allergan is a healthcare company focused on developing and commercializing pharmaceuticals, biologics, and medical devices. For more information, get Portfolio Grader’s complete analysis of AGN stock.
Since January 1, Marcus & Millichap, Inc. (MMI) has shot up 56.1%. Marcus & Millichap, a brokerage company, provides various investment brokerage and financing services to sellers and buyers of various types and sizes of commercial real estate properties in the United States. For more information, get Portfolio Grader’s complete analysis of MMI stock.
Since January 1, the price of Sucampo Pharmaceuticals, Inc. Class A (SCMP) has grown 60.3%. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.
The price of China Biologic Products, Inc. (CBPO) is up 82.4% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
The price of Ebix, Inc. (EBIX) has seen an 85.6% boost since the first of the year. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. Trade volume rose notably over the past week, up 190.8%. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
Since January 1, Ellie Mae, Inc. (ELLI) has climbed 91.5%. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.
Since the first of the year, shares of ABIOMED, Inc. (ABMD) have soared 111.2%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. Trade volume has increased significantly over the past week, up 312.6%. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Skechers U.S.A., Inc. Class A (SKX) has risen 166.4% since the first of the year. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.
Since January 1, Chimera Investment Corporation (CIM) has jumped 317.6%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock currently has a trailing PE Ratio of 5.30. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
